-
1
-
-
0031737671
-
Vascular permeability in experimental diabetes is associated with reduced endothelial occludin content. Vascular endothelial growth factor decreases occludin in retinal endothelial cells
-
D.A. Antonetti, A.J. Barber, S. Khin, E. Lieth, J.M. Tarbell, and T.W. Gardner Vascular permeability in experimental diabetes is associated with reduced endothelial occludin content : vascular endothelial growth factor decreases occludin in retinal endothelial cells Diabetes 47 1998 1953 1959 (Pubitemid 28549205)
-
(1998)
Diabetes
, vol.47
, Issue.12
, pp. 1953-1959
-
-
Antonetti, D.A.1
Barber, A.J.2
Khin, S.3
Lieth, E.4
Tarbell, J.M.5
Gardner, T.W.6
-
2
-
-
0037376768
-
A new view of diabetic retinopathy: A neurodegenerative disease of the eye
-
DOI 10.1016/S0278-5846(03)00023-X
-
A.J. Barber A new view of diabetic retinopathy: a neurodegenerative disease of the eye Prog. Neuro-Psychopharmacol. Biol. Psychiatry 27 2003 283 290 (Pubitemid 36351495)
-
(2003)
Progress in Neuro-Psychopharmacology and Biological Psychiatry
, vol.27
, Issue.2
, pp. 283-290
-
-
Barber, A.J.1
-
3
-
-
0346777254
-
Vascular endothelial growth factor and diabetic retinopathy: Pathophysiological mechanisms and treatment perspectives
-
DOI 10.1002/dmrr.415
-
R.B. Caldwell, M. Bartoli, M.A. Behzadian, A.E.B. El-Remessy, M. Al-Shabrawey, D.H. Platt, and R.W. Caldwell Vascular endothelial growth factor and diabetic retinopathy: pathophysiological mechanisms and treatment perspectives Diabetes Metab. Res. Rev 19 2003 442 455 (Pubitemid 37536961)
-
(2003)
Diabetes/Metabolism Research and Reviews
, vol.19
, Issue.6
, pp. 442-455
-
-
Caldwell, R.B.1
Bartoli, M.2
Behzadian, M.A.3
El-Remessy, A.E.B.4
Al-Shabrawey, M.5
Platt, D.H.6
Caldwell, R.W.7
-
4
-
-
0033611142
-
Cingulin contains globular and coiled-coil domains and interacts with ZO-1, ZO-2, ZO-3, and myosin
-
DOI 10.1083/jcb.147.7.1569
-
M. Cordenonsi, F. D'Atri, E. Hammar, D.A.D. Parry, J. Kendrick-Jones, D. Shore, and S. Citi Cingulin contains globular and coiled-coil domains and interacts with ZO-1, ZO-2, ZO-3, and myosin J. Cell Biol. 147 1999 1569 1581 (Pubitemid 30027410)
-
(1999)
Journal of Cell Biology
, vol.147
, Issue.7
, pp. 1569-1581
-
-
Cordenonsi, M.1
D'Atri, F.2
Hammar, E.3
Parry, D.A.D.4
Kendrick-Jones, J.5
Shore, D.6
Citi, S.7
-
5
-
-
0034807581
-
Cytoskeletal regulation of pulmonary vascular permeability
-
S.M. Dudek, and J.G.N. Garcia Cytoskeletal regulation of pulmonary vascular permeability J. Appl. Physiol. 91 2001 1487 1500 (Pubitemid 32900340)
-
(2001)
Journal of Applied Physiology
, vol.91
, Issue.4
, pp. 1487-1500
-
-
Dudek, S.M.1
Garcia, J.G.N.2
-
6
-
-
0034799675
-
Sphingosine 1-phosphate promotes endothelial cell barrier integrity by Edg-dependent cytoskeletal rearrangement
-
DOI 10.1172/JCI200112450
-
J.G.N. Garcia, F. Liu, A.D. Verin, A. Birukova, M.A. Dechert, W.T. Gerthoffer, J.R. Bamburg, and D. English Sphingosine 1-phosphate promotes endothelial cell barrier integrity by Edg-dependent cytoskeletal rearrangement J. Clin. Invest 108 2001 689 701 (Pubitemid 32906197)
-
(2001)
Journal of Clinical Investigation
, vol.108
, Issue.5
, pp. 689-701
-
-
Garcia, J.G.N.1
Liu, F.2
Verin, A.D.3
Birukova, A.4
Dechert, M.A.5
Gerthoffer, W.T.6
Bamburg, J.R.7
English, D.8
-
7
-
-
1942502810
-
Regulation of tight junctions and loss of barrier function in pathophysiology
-
DOI 10.1016/j.biocel.2003.08.007, PII S1357272503002978
-
N.S. Harhaj, and D.A. Antonetti Regulation of tight junctions and loss of barrier function in pathophysiology Int. J. Biochem. Cell Biol. 36 2004 1206 1237 (Pubitemid 38519069)
-
(2004)
International Journal of Biochemistry and Cell Biology
, vol.36
, Issue.7
, pp. 1206-1237
-
-
Harhaj, N.S.1
Antonetti, D.A.2
-
8
-
-
0032489875
-
ZO-3, a novel member of the MAGUK protein family found at the tight junction, interacts with ZO-1 and occludin
-
DOI 10.1083/jcb.141.1.199
-
J. Haskins, L. Gu, E.S. Wittchen, J. Hibbard, and B.R. Stevenson ZO-3, a novel member of the MAGUK protein family found at the tight junction, interacts with ZO-1 and occludin J. Cell Biol. 141 1998 199 208 (Pubitemid 28182652)
-
(1998)
Journal of Cell Biology
, vol.141
, Issue.1
, pp. 199-208
-
-
Haskins, J.1
Gu, L.2
Wittchen, E.S.3
Hibbard, J.4
Stevenson, B.R.5
-
9
-
-
55849146641
-
Blood-retinal barrier in hypoxic ischaemic conditions: Basic concepts, clinical features and management
-
C. Kaur, W.S. Foulds, and E.A. Ling Blood-retinal barrier in hypoxic ischaemic conditions: basic concepts, clinical features and management Prog Retin Eye Res 27 2008 622 647
-
(2008)
Prog Retin Eye Res
, vol.27
, pp. 622-647
-
-
Kaur, C.1
Foulds, W.S.2
Ling, E.A.3
-
10
-
-
78149284009
-
Cholesterol-derived novel anti-apoptotic agents on the structural basis of ginsenoside
-
Lee, S., Maharjan, S., Kim, K., Kim, N.J., Choi, H.J., Kwon, Y.G., Suh, Y.G., 2010. Cholesterol-derived novel anti-apoptotic agents on the structural basis of ginsenoside Rk1. Bioorg. Med. Chem. Lett. 20, 7102-7105.
-
(2010)
Rk1. Bioorg. Med. Chem. Lett.
, vol.20
, pp. 7102-7105
-
-
Lee, S.1
Maharjan, S.2
Kim, K.3
Kim, N.J.4
Choi, H.J.5
Kwon, Y.G.6
Suh, Y.G.7
-
12
-
-
33644839612
-
Signaling mechanisms regulating endothelial permeability
-
D. Mehta, and A.B. Malik Signaling mechanisms regulating endothelial permeability Physiol. Rev. 86 2006 279 367
-
(2006)
Physiol. Rev.
, vol.86
, pp. 279-367
-
-
Mehta, D.1
Malik, A.B.2
-
13
-
-
33748633513
-
20(S)-Ginsenoside Rg3 prevents endothelial cell apoptosis via inhibition of a mitochondrial caspase pathway
-
DOI 10.1016/j.bbrc.2006.08.129, PII S0006291X06019383
-
J.K. Min, J.H. Kim, Y.L. Cho, Y.S. Maeng, S.J. Lee, B.J. Pyun, Y.M. Kim, J.H. Park, and Y.G. Kwon 20(S)-Ginsenoside Rg3 prevents endothelial cell apoptosis via inhibition of a mitochondrial caspase pathway Biochem. Biophys. Res. Commun. 349 2006 987 994 (Pubitemid 44380196)
-
(2006)
Biochemical and Biophysical Research Communications
, vol.349
, Issue.3
, pp. 987-994
-
-
Min, J.-K.1
Kim, J.-H.2
Cho, Y.-L.3
Maeng, Y.-S.4
Lee, S.-J.5
Pyun, B.-J.6
Kim, Y.-M.7
Park, J.H.8
Kwon, Y.-G.9
-
14
-
-
39149100314
-
Capsiate, a nonpungent capsaicin-like compound, inhibits angiogenesis and vascular permeability via a direct inhibition of Src kinase activity
-
DOI 10.1158/0008-5472.CAN-07-2799
-
B.J. Pyun, S. Choi, Y. Lee, T.W. Kim, J.K. Min, Y. Kim, B.D. Kim, J.H. Kim, T.Y. Kim, Y.M. Kim, and Y.G. Kwon Capsiate, a nonpungent capsaicin-like compound, inhibits angiogenesis and vascular permeability via a direct inhibition of Src kinase activity Cancer Res 68 2008 227 235 (Pubitemid 351380124)
-
(2008)
Cancer Research
, vol.68
, Issue.1
, pp. 227-235
-
-
Pyun, B.-J.1
Choi, S.2
Lee, Y.3
Kim, T.-W.4
Min, J.-K.5
Kim, Y.6
Kim, B.-D.7
Kim, J.-H.8
Kim, T.-Y.9
Kim, Y.-M.10
Kwon, Y.-G.11
-
15
-
-
67650236573
-
(Pro)renin receptor-mediated signal transduction and tissue renin-angiotensin system contribute to diabetes-induced retinal inflammation
-
S. Satofuka, A. Ichihara, N. Nagai, K. Noda, Y. Ozawa, A. Fukamizu, K. Tsubota, H. Itoh, Y. Oike, and S. Ishida (Pro)renin receptor-mediated signal transduction and tissue renin-angiotensin system contribute to diabetes-induced retinal inflammation Diabetes 58 2009 1625 1633
-
(2009)
Diabetes
, vol.58
, pp. 1625-1633
-
-
Satofuka, S.1
Ichihara, A.2
Nagai, N.3
Noda, K.4
Ozawa, Y.5
Fukamizu, A.6
Tsubota, K.7
Itoh, H.8
Oike, Y.9
Ishida, S.10
-
16
-
-
45749143528
-
Retinal vascular permeability suppression by topical application of a novel VEGFR2/Src kinase inhibitor in mice and rabbits
-
DOI 10.1172/JCI33361
-
L. Scheppke, E. Aguilar, R.F. Gariano, R. Jacobson, J. Hood, J. Doukas, J. Cao, G. Noronha, S. Yee, S. Weis, M.B. Martin, R. Soll, D.A. Cheresh, and M. Friedlander Retinal vascular permeability suppression by topical application of a novel VEGFR2/Src kinase inhibitor in mice and rabbits J. Clin. Invest 118 2008 2337 2346 (Pubitemid 351872350)
-
(2008)
Journal of Clinical Investigation
, vol.118
, Issue.6
, pp. 2337-2346
-
-
Scheppke, L.1
Aguilar, E.2
Gariano, R.F.3
Jacobson, R.4
Hood, J.5
Doukas, J.6
Cao, J.7
Noronha, G.8
Yee, S.9
Weis, S.10
Martin, M.B.11
Soll, R.12
Cheresh, D.A.13
Friedlander, M.14
-
17
-
-
40649099152
-
Characterization of azurocidin as a permeability factor in the retina: Involvement in VEGF-induced and early diabetic blood-retinal barrier breakdown
-
D. Skondra, K. Noda, L. Almulki, F. Tayyari, S. Frimmel, T. Nakazawa, I.K. Kim, S. Zandi, K.L. Thomas, J.W. Miller, E.S. Gragoudas, and A. Hafezi-Moghadam Characterization of azurocidin as a permeability factor in the retina: involvement in VEGF-induced and early diabetic blood-retinal barrier breakdown Invest. Ohthalmol. Vis. Sci. 49 2008 726 731
-
(2008)
Invest. Ohthalmol. Vis. Sci.
, vol.49
, pp. 726-731
-
-
Skondra, D.1
Noda, K.2
Almulki, L.3
Tayyari, F.4
Frimmel, S.5
Nakazawa, T.6
Kim, I.K.7
Zandi, S.8
Thomas, K.L.9
Miller, J.W.10
Gragoudas, E.S.11
Hafezi-Moghadam, A.12
-
18
-
-
0035021651
-
VEGF increases BMEC monolayer permeability by affecting occludin expression and tight junction assembly
-
W. Wang, W.L. Dentler, and R.T. Borchardt VEGF increases BMEC monolayer permeability by affecting occludin expression and tight junction assembly Am. J. Physiol. Heart Circ. Physiol 280 2001 H434 H440
-
(2001)
Am. J. Physiol. Heart Circ. Physiol
, vol.280
-
-
Wang, W.1
Dentler, W.L.2
Borchardt, R.T.3
-
19
-
-
0034942273
-
Pathogenesis and intervention strategies in diabetic retinopathy
-
DOI 10.1046/j.1442-9071.2001.00409.x
-
D.Y. Yu, S.J. Cringle, E.N. Su, P.K. Yu, G. Jerums, and M.E. Cooper Pathogenesis and intervention strategies in diabetic retinopathy Clin. Experiment. Ophthalmol. 29 2001 164 166 (Pubitemid 32618982)
-
(2001)
Clinical and Experimental Ophthalmology
, vol.29
, Issue.3
, pp. 164-166
-
-
Yu, D.-Y.1
Cringle, S.J.2
Su, E.-N.3
Yu, P.K.4
Jerums, G.5
Cooper, M.E.6
|